What is the current valuation of the biologic therapy market in South Korea?

The market valuation was $7.8 Billion in 2024. Read More

What is the projected market size for biologic therapy in South Korea by 2035?

The market is expected to reach $15.9 Billion by 2035. Read More

What is the expected CAGR for the South Korea biologic therapy market from 2025 to 2035?

The expected CAGR during this period is 6.69%. Read More

Which companies are the key players in the South Korea biologic therapy market?

Key players include AbbVie, Amgen, Roche, Johnson & Johnson, Novartis, Pfizer, Bristol-Myers Squibb, Sanofi, and Gilead Sciences. Read More

How did the market for Monoclonal Antibodies perform in 2024?

The market for Monoclonal Antibodies was valued at $2.5 Billion in 2024 and is projected to reach $5.2 Billion by 2035. Read More

What applications dominate the biologic therapy market in South Korea?

Oncology and Autoimmune Diseases are the dominant applications, each valued at $2.34 Billion in 2024. Read More

What routes of administration are prevalent in the biologic therapy market?

Intravenous and Subcutaneous routes are prevalent, each valued at $2.34 Billion in 2024. Read More

What are the primary end-users of biologic therapy in South Korea?

Hospitals are the primary end-users, with a market value of $3.12 Billion in 2024. Read More

How is the market for Cell Therapy expected to grow by 2035?

The market for Cell Therapy is projected to grow from $1.2 Billion in 2024 to $2.5 Billion by 2035. Read More

South Korea Biologic Therapy Market

Q: What are the main segments of the biologic therapy market in South Korea?

The main segments include Monoclonal Antibodies, Vaccines, Cell Therapy, and Gene Therapy. Read More

ID: MRFR/Pharma/52743-HCR

200 Pages

Rahul Gotadki

Last Updated: February 06, 2026

South Korea Biologic Therapy Market Research Report By Therapy Type (Monoclonal Antibodies, Vaccines, Cell Therapy, Gene Therapy), By Application (Oncology, Autoimmune Diseases, Infectious Diseases, Cardiovascular Diseases), By Route of Administration (Intravenous, Subcutaneous, Intramuscular) and By End User (Hospitals, Clinics, Home Healthcare) - Growth & Industry Forecast 2025 To 2035

South Korea Biologic Therapy Market Infographic

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1.1 EXECUTIVE SUMMARY
1.1.1 Market Overview
1.1.2 Key Findings
1.1.3 Market Segmentation
1.1.4 Competitive Landscape
1.1.5 Challenges and Opportunities
1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
2.1 MARKET INTRODUCTION
2.1.1 Definition
2.1.2 Scope of the study
2.1.2.1 Research Objective
2.1.2.2 Assumption
2.1.2.3 Limitations
2.2 RESEARCH METHODOLOGY
2.2.1 Overview
2.2.2 Data Mining
2.2.3 Secondary Research
2.2.4 Primary Research
2.2.4.1 Primary Interviews and Information Gathering Process
2.2.4.2 Breakdown of Primary Respondents
2.2.5 Forecasting Model
2.2.6 Market Size Estimation
2.2.6.1 Bottom-Up Approach
2.2.6.2 Top-Down Approach
2.2.7 Data Triangulation
2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
3.1 MARKET DYNAMICS
3.1.1 Overview
3.1.2 Drivers
3.1.3 Restraints
3.1.4 Opportunities
3.2 MARKET FACTOR ANALYSIS
3.2.1 Value chain Analysis
3.2.2 Porter's Five Forces Analysis
3.2.2.1 Bargaining Power of Suppliers
3.2.2.2 Bargaining Power of Buyers
3.2.2.3 Threat of New Entrants
3.2.2.4 Threat of Substitutes
3.2.2.5 Intensity of Rivalry
3.2.3 COVID-19 Impact Analysis
3.2.3.1 Market Impact Analysis
3.2.3.2 Regional Impact
3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
4.1 Industrial Automation & Equipment, BY Type (USD Billion)
4.1.1 Monoclonal Antibodies
4.1.2 Vaccines
4.1.3 Cell Therapy
4.1.4 Gene Therapy
4.2 Industrial Automation & Equipment, BY Application (USD Billion)
4.2.1 Oncology
4.2.2 Autoimmune Diseases
4.2.3 Infectious Diseases
4.2.4 Cardiovascular Diseases
4.3 Industrial Automation & Equipment, BY Route of Administration (USD Billion)
4.3.1 Intravenous
4.3.2 Subcutaneous
4.3.3 Intramuscular
4.4 Industrial Automation & Equipment, BY End-user (USD Billion)
4.4.1 Hospitals
4.4.2 Clinics
4.4.3 Home Healthcare
5 SECTION V: COMPETITIVE ANALYSIS
5.1 Competitive Landscape
5.1.1 Overview
5.1.2 Competitive Analysis
5.1.3 Market share Analysis
5.1.4 Major Growth Strategy in the Industrial Automation & Equipment
5.1.5 Competitive Benchmarking
5.1.6 Leading Players in Terms of Number of Developments in the Industrial Automation & Equipment
5.1.7 Key developments and growth strategies
5.1.7.1 New Product Launch/Service Deployment
5.1.7.2 Merger & Acquisitions
5.1.7.3 Joint Ventures
5.1.8 Major Players Financial Matrix
5.1.8.1 Sales and Operating Income
5.1.8.2 Major Players R&D Expenditure. 2023
5.2 Company Profiles
5.2.1 AbbVie (US)
5.2.1.1 Financial Overview
5.2.1.2 Products Offered
5.2.1.3 Key Developments
5.2.1.4 SWOT Analysis
5.2.1.5 Key Strategies
5.2.2 Amgen (US)
5.2.2.1 Financial Overview
5.2.2.2 Products Offered
5.2.2.3 Key Developments
5.2.2.4 SWOT Analysis
5.2.2.5 Key Strategies
5.2.3 Roche (CH)
5.2.3.1 Financial Overview
5.2.3.2 Products Offered
5.2.3.3 Key Developments
5.2.3.4 SWOT Analysis
5.2.3.5 Key Strategies
5.2.4 Johnson & Johnson (US)
5.2.4.1 Financial Overview
5.2.4.2 Products Offered
5.2.4.3 Key Developments
5.2.4.4 SWOT Analysis
5.2.4.5 Key Strategies
5.2.5 Novartis (CH)
5.2.5.1 Financial Overview
5.2.5.2 Products Offered
5.2.5.3 Key Developments
5.2.5.4 SWOT Analysis
5.2.5.5 Key Strategies
5.2.6 Pfizer (US)
5.2.6.1 Financial Overview
5.2.6.2 Products Offered
5.2.6.3 Key Developments
5.2.6.4 SWOT Analysis
5.2.6.5 Key Strategies
5.2.7 Bristol-Myers Squibb (US)
5.2.7.1 Financial Overview
5.2.7.2 Products Offered
5.2.7.3 Key Developments
5.2.7.4 SWOT Analysis
5.2.7.5 Key Strategies
5.2.8 Sanofi (FR)
5.2.8.1 Financial Overview
5.2.8.2 Products Offered
5.2.8.3 Key Developments
5.2.8.4 SWOT Analysis
5.2.8.5 Key Strategies
5.2.9 Gilead Sciences (US)
5.2.9.1 Financial Overview
5.2.9.2 Products Offered
5.2.9.3 Key Developments
5.2.9.4 SWOT Analysis
5.2.9.5 Key Strategies
5.3 Appendix
5.3.1 References
5.3.2 Related Reports
6 LIST OF FIGURES
6.1 MARKET SYNOPSIS
6.2 SOUTH KOREA MARKET ANALYSIS BY TYPE
6.3 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
6.4 SOUTH KOREA MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
6.5 SOUTH KOREA MARKET ANALYSIS BY END-USER
6.6 KEY BUYING CRITERIA OF INDUSTRIAL AUTOMATION & EQUIPMENT
6.7 RESEARCH PROCESS OF MRFR
6.8 DRO ANALYSIS OF INDUSTRIAL AUTOMATION & EQUIPMENT
6.9 DRIVERS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
6.10 RESTRAINTS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
6.11 SUPPLY / VALUE CHAIN: INDUSTRIAL AUTOMATION & EQUIPMENT
6.12 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TYPE, 2024 (% SHARE)
6.13 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TYPE, 2024 TO 2035 (USD Billion)
6.14 INDUSTRIAL AUTOMATION & EQUIPMENT, BY APPLICATION, 2024 (% SHARE)
6.15 INDUSTRIAL AUTOMATION & EQUIPMENT, BY APPLICATION, 2024 TO 2035 (USD Billion)
6.16 INDUSTRIAL AUTOMATION & EQUIPMENT, BY ROUTE OF ADMINISTRATION, 2024 (% SHARE)
6.17 INDUSTRIAL AUTOMATION & EQUIPMENT, BY ROUTE OF ADMINISTRATION, 2024 TO 2035 (USD Billion)
6.18 INDUSTRIAL AUTOMATION & EQUIPMENT, BY END-USER, 2024 (% SHARE)
6.19 INDUSTRIAL AUTOMATION & EQUIPMENT, BY END-USER, 2024 TO 2035 (USD Billion)
6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
7.1 LIST OF ASSUMPTIONS
7.1.1
7.2 South Korea MARKET SIZE ESTIMATES; FORECAST
7.2.1 BY TYPE, 2025-2035 (USD Billion)
7.2.2 BY APPLICATION, 2025-2035 (USD Billion)
7.2.3 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
7.2.4 BY END-USER, 2025-2035 (USD Billion)
7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

South Korea Industrial Automation & Equipment Market Segmentation

Industrial Automation & Equipment By Type (USD Billion, 2025-2035)

Monoclonal Antibodies
Vaccines
Cell Therapy
Gene Therapy

Industrial Automation & Equipment By Application (USD Billion, 2025-2035)

Oncology
Autoimmune Diseases
Infectious Diseases
Cardiovascular Diseases

Industrial Automation & Equipment By Route of Administration (USD Billion, 2025-2035)

Intravenous
Subcutaneous
Intramuscular

Industrial Automation & Equipment By End-user (USD Billion, 2025-2035)

Hospitals
Clinics
Home Healthcare

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓